Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quality Improvement | 12 | 2016 | 417 | 2.120 |
Why?
|
| Delivery of Health Care | 7 | 2018 | 411 | 2.030 |
Why?
|
| Quality Assurance, Health Care | 5 | 2013 | 250 | 1.530 |
Why?
|
| Health Care Reform | 3 | 2018 | 85 | 1.160 |
Why?
|
| Organizational Innovation | 5 | 2018 | 81 | 0.880 |
Why?
|
| Cross Infection | 3 | 2009 | 149 | 0.840 |
Why?
|
| Staphylococcal Infections | 3 | 2009 | 122 | 0.790 |
Why?
|
| Hospitals | 4 | 2016 | 377 | 0.790 |
Why?
|
| Data Interpretation, Statistical | 3 | 2021 | 191 | 0.790 |
Why?
|
| Philosophy | 2 | 2013 | 12 | 0.790 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 37 | 0.750 |
Why?
|
| Audiovisual Aids | 1 | 2021 | 11 | 0.730 |
Why?
|
| Data Collection | 2 | 2013 | 371 | 0.730 |
Why?
|
| Epidemiologic Methods | 1 | 2021 | 65 | 0.720 |
Why?
|
| Models, Organizational | 3 | 2018 | 92 | 0.710 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2009 | 62 | 0.610 |
Why?
|
| Population Surveillance | 2 | 2009 | 195 | 0.570 |
Why?
|
| Hospitals, Community | 5 | 2011 | 70 | 0.570 |
Why?
|
| Infection Control | 2 | 2009 | 94 | 0.520 |
Why?
|
| Models, Theoretical | 2 | 2015 | 256 | 0.520 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 259 | 0.510 |
Why?
|
| Patient Safety | 2 | 2014 | 237 | 0.440 |
Why?
|
| Health Care Costs | 1 | 2015 | 202 | 0.440 |
Why?
|
| Research Design | 2 | 2021 | 555 | 0.430 |
Why?
|
| Quality of Health Care | 3 | 2013 | 513 | 0.410 |
Why?
|
| Information Dissemination | 2 | 2016 | 111 | 0.410 |
Why?
|
| Science | 1 | 2013 | 34 | 0.410 |
Why?
|
| Diffusion of Innovation | 2 | 2011 | 56 | 0.400 |
Why?
|
| Judgment | 1 | 2012 | 34 | 0.390 |
Why?
|
| Safety Management | 1 | 2013 | 137 | 0.390 |
Why?
|
| United States | 11 | 2018 | 7426 | 0.380 |
Why?
|
| Medical Errors | 1 | 2013 | 195 | 0.370 |
Why?
|
| Physics | 1 | 2011 | 12 | 0.370 |
Why?
|
| Health Services Misuse | 1 | 2011 | 18 | 0.360 |
Why?
|
| Health Resources | 1 | 2011 | 88 | 0.350 |
Why?
|
| Economics, Hospital | 1 | 2010 | 14 | 0.350 |
Why?
|
| Disease Notification | 1 | 2009 | 5 | 0.320 |
Why?
|
| Humans | 25 | 2021 | 59366 | 0.320 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2011 | 725 | 0.320 |
Why?
|
| Organizational Case Studies | 2 | 2018 | 40 | 0.290 |
Why?
|
| Health Personnel | 1 | 2011 | 342 | 0.290 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 210 | 0.280 |
Why?
|
| Learning | 1 | 2009 | 169 | 0.280 |
Why?
|
| Fluoroquinolones | 1 | 2007 | 31 | 0.270 |
Why?
|
| Psychometrics | 1 | 2008 | 362 | 0.270 |
Why?
|
| Hospitalization | 1 | 2013 | 1290 | 0.260 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2005 | 3 | 0.250 |
Why?
|
| Vancomycin Resistance | 1 | 2005 | 3 | 0.250 |
Why?
|
| Equipment Contamination | 1 | 2005 | 31 | 0.250 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 169 | 0.220 |
Why?
|
| Bacteria | 1 | 2005 | 278 | 0.200 |
Why?
|
| Escherichia coli | 1 | 2007 | 695 | 0.200 |
Why?
|
| Leadership | 2 | 2014 | 195 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 734 | 0.160 |
Why?
|
| Computer Simulation | 1 | 2021 | 458 | 0.150 |
Why?
|
| Intensive Care Units | 1 | 2021 | 423 | 0.150 |
Why?
|
| Food Assistance | 1 | 2018 | 17 | 0.140 |
Why?
|
| Pandemics | 1 | 2021 | 616 | 0.130 |
Why?
|
| Cost Control | 1 | 2015 | 24 | 0.130 |
Why?
|
| Total Quality Management | 2 | 2013 | 56 | 0.120 |
Why?
|
| Efficiency, Organizational | 2 | 2011 | 93 | 0.110 |
Why?
|
| Medical Audit | 1 | 2014 | 58 | 0.110 |
Why?
|
| Organizational Culture | 2 | 2011 | 106 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2018 | 619 | 0.110 |
Why?
|
| Bibliometrics | 1 | 2013 | 27 | 0.110 |
Why?
|
| Clinical Coding | 1 | 2013 | 44 | 0.110 |
Why?
|
| Probability | 1 | 2013 | 167 | 0.100 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 129 | 0.100 |
Why?
|
| Physician's Role | 1 | 2014 | 120 | 0.100 |
Why?
|
| Sampling Studies | 1 | 2012 | 65 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2013 | 223 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2011 | 2516 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 154 | 0.100 |
Why?
|
| Education, Continuing | 1 | 2011 | 23 | 0.090 |
Why?
|
| Social Networking | 1 | 2011 | 23 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2016 | 841 | 0.090 |
Why?
|
| Delphi Technique | 1 | 2011 | 77 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 246 | 0.090 |
Why?
|
| Sample Size | 1 | 2010 | 61 | 0.090 |
Why?
|
| Global Health | 1 | 2011 | 167 | 0.090 |
Why?
|
| Life Expectancy | 1 | 2010 | 34 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2010 | 93 | 0.080 |
Why?
|
| Oxazolidinones | 1 | 2009 | 13 | 0.080 |
Why?
|
| Creatine Kinase | 1 | 2009 | 41 | 0.080 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2009 | 11 | 0.080 |
Why?
|
| Acetamides | 1 | 2009 | 12 | 0.080 |
Why?
|
| Poisson Distribution | 1 | 2009 | 52 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 297 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 442 | 0.080 |
Why?
|
| Observer Variation | 1 | 2008 | 205 | 0.070 |
Why?
|
| Program Development | 1 | 2009 | 203 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 409 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2009 | 486 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 143 | 0.070 |
Why?
|
| Health Status | 1 | 2010 | 425 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2010 | 814 | 0.070 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 83 | 0.070 |
Why?
|
| Laboratories, Hospital | 1 | 2005 | 9 | 0.060 |
Why?
|
| Penicillin Resistance | 1 | 2005 | 11 | 0.060 |
Why?
|
| Health Promotion | 1 | 2010 | 471 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2011 | 647 | 0.060 |
Why?
|
| Logistic Models | 1 | 2009 | 1235 | 0.060 |
Why?
|
| Vancomycin | 1 | 2005 | 36 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1559 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2005 | 189 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2009 | 6069 | 0.030 |
Why?
|
| Adult | 2 | 2014 | 15679 | 0.030 |
Why?
|
| Male | 3 | 2014 | 27742 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 332 | 0.030 |
Why?
|
| Decision Making, Organizational | 1 | 2011 | 25 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2011 | 57 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 398 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2010 | 20 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2010 | 52 | 0.020 |
Why?
|
| Linezolid | 1 | 2009 | 6 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 589 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2009 | 25 | 0.020 |
Why?
|
| Mortality | 1 | 2010 | 155 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2010 | 137 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2010 | 279 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 742 | 0.020 |
Why?
|
| Health Behavior | 1 | 2010 | 452 | 0.020 |
Why?
|
| Massachusetts | 1 | 2011 | 2019 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 16310 | 0.010 |
Why?
|
| Aged | 1 | 2009 | 13405 | 0.010 |
Why?
|
| Female | 1 | 2014 | 30719 | 0.010 |
Why?
|